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1. Introduction growth of sarcoma 180 tumors implanted in hybrid 
mice [7]. 
The increasing knowledge of the physio-pathological 
importance of serine proteases has stimulated interest 
in the search for effective and selective inhibitors of 
these enzymes. The interest is also justified by the 
potential therapeutic value as drugs, of the inhibitors 
[ll. 
The development of synthetic competitive inhib- 
itors of trypsin-like proteases has been greatly influ- 
enced by Mares-Guia and Shaw’s discovery of the 
effectiveness of benzamidine as an anti-trypsin agent 
[A. 
This paper reports the inhibition by TAPP,of the 
catalysed hydrolysis of p-nitrophenyl esters by bovine 
Ptrypsin, bovine thrombin, human urinary kallikrein, 
human urokinase, bovine cu-chymotrypsin, and bovine 
pancreatic elastase, in comparison with benzamidine. 
The results indicate that the interaction with TAPP 
reflects structural differences in the specificity site of 
the various enzymes. 
2. Materials and methods 
A significant advance is represented by the finding 
that the link-up of 2 or 3 benzamidine moieties by 
aliphatic or arylaliphatic chains markedly enhances 
the inhibitory effect, both in vitro and in vivo (beyond 
that of mono-aminidines) on serine protease catalysis 
[3-61. 
The in vivo effect of bis- and tris-amidines, as inhib- 
itors of serine proteases, directed our attention to an 
even higher protonated compound: tetra-p-amidino- 
phenoxy-propane (TAPP). This compound inhibits, 
in vitro, the ‘cancer coagulation factor’ produced by 
the Walker carcinoma in Wistar rats and, in vivo, the 
Human urinary kallikrein, kindly provided by 
‘Lepetit S.p.A.‘, was prepared according to [8]. Bovine 
fl-trypsin (treated with diphenylcarbamyl chloride to 
abolish chymotryptic activity), bovine thrombin and 
porcine pancreatic elastase were obtained from Sigma 
Chemical Co. Both forms ofhuman urokinase (33 000 
and 54 000 M,) were provided by ‘Serono S.p.A.’ 
(details in [9]). Bovine cY-chymotrypsin was obtained 
from Worthington Chemical Co. The characterization 
of the enzyme preparations used has been reported 
in [lo-121. 
Abbreviations ZLysONp, a-carbobenzoxy-l-lysine-p-nitro- 
phenyl ester; ZAlaONp, or-carbobenzoxy-l-alanine-p-nitro- 
phenyl ester; ZTyrONp, cr-carbobenzoxy-L-tyrosine-p-nitro- 
phenyl ester; TAPP, tetra-p-amidinophenoxy-propane: 
The substrates ZLysONp, ZTyrONp and ZAlaONp 
were obtained from Sigma Chemical Co. Benzamidine 
was obtained from Merck. TAPP was synthetised 
according to [7]. 
C-(CH,-0-C,H,-C 
< NH1+)4 NH, 
t To whom correspondence should be addressed 
Values of the dissociation constants for TAPP and 
benzamidine binding to the enzymes examined have 
been determined: 
(i) By the inhibitory effect (Ki) on the bovine P-tryp- 
sin, human urinary kallikrein, human urokinase 
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and bovine thrombin-catalysed hydrolysis of 
ZLysONp; on bovine o-chymotrypsincatalysed 
hydrolysis of ZLysONp and ZTyrONp and on 
porcine pancreatic elastasecatalysed hydrolysis 
of ZAlaONp; 
(ii) By spectrophotometric titrations over 220- 
270 nm, (K,), as reported in [ 11,121. 
Under all the experimental conditions, the inhibition 
of the enzyme activity and the spectrophotometric 
titrations conform to a simple equilibrium (E + I + EI). 
Calcium was never present in the reaction mixtures. 
The pH profile was explored using the following 
buffers: phosphate (pH 2-3 S), acetate (pH 3.5-6) 
phosphate (pH 6-8.5), all at 0.1 M (sodium salts). 
The spectrophotometric measurements were car- 
ried out with a double-beam spectrophotometer (Cary 
118 or 219). 
AI1 the measurements were performed at 21+ 0.5”C. 
The biological assay of bovine thrombin was done 
as in [13]. 
3. Results 
The pH dependence of the dissociation constants 
(expressed as Ki and K,) for TAPP and benzamidine 
binding to bovine fl-trypsin, human u&&y kallikrein 
and human urokinase (fig.1) may be fitted with a 
simple pH transition with av. pKa 4.1. No pH depen- 
dence of the values of the dissociation constants for 
bovine o-chymotrypsin was observed. TAPP shows a 
lower affinity than benzamidine for all these enzymes. 
The pH dependence of the dissociation constant 
for the benzamidine binding to bovine thrombin 
(fig.2) also corresponds to a simple pH transition with 
pK, 4.1. However, the pH dependence of the disso- 
ciation constant for TAPP to bovine thrombin (fig.2) 
has a mid-point at pH 4.1, but is much steeper than 
that corresponding to pK changes of a single ionizing 
group. 
Contrary to the other enzymes, at pH > 3.9, TAPP 
has an higher affinity than benzamidine for bovine 
thrombin. At pH 7, TAPP has an inhibitory effect 
higher than benzamidine (-1 order of magnitude) on 
the bovine thrombin-catalysed interconversion of 
fibrinogen to fibrin. 
The stoichiometry of the reaction of TAPP with 
bovine thrombin (1: 1) was verified, by spectrophoto- 
metric titrations, at pH 3.3 and 6.5 at 600 and 50 PM 
bovine thrombin, respectively (i.e., at concentrations 
much higher than Ki and K,). 
34 
In agreement with the absence of the inhibitory 
effect of TAPP and benzamidine on porcine pancreatic 
elastase catalysis, no spectral changes reflecting the 
binding of these 2 cations have been observed. 
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Fig.1. pH-Dependence of the dissociation constants for the 
reaction of TAPP (filled symbols) and benzamidine (open 
symbols) with bovine cY-chymotrypsin (A), human urokinase 
(B), bovine p-trypsin (C) and human urinary kallikrein (D) at 
21°C. Both forms of human urokinase (33 000 and 54 000 
MI) show indistinguishable ligand binding constants. The data 
have been obtained: (i) by the inhibition effect on the enzy- 
matic hydrolysis of ZLysONp (squares) and ZTyrONp (cir- 
cles); (ii) by spectrophotometric titrations (triangles). Contin- 
uous lines were calculated from eq. (1) with values of KUNL 
and KLI~ shown in table 1. 
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Fig.2. pH Dependence of the dissociation constants for the 
reaction of TAPP and benzamidine with bovine thrombin at 
21°C. Dotted line was calculated from eq. (2) with values of 
KUNL and KLIG shown in table 1. For the other symbols 
and conventions see fii.1. 
4. Discussion 
This paper provides a comparison of the inhibitory 
effects of TAPP and benzamidine on the catalytic prop- 
erties of bovine thrombin, bovine fl-trypsin, human 
urokinase, human urinary kalllkrein, all acting on cati- 
onic substrates, and bovine achymotrypsin and porcine 
pancreatic elastase, both acting on neutral substrates. 
The higher affinity of bovine thrombin and human 
urinary kallikrein for TAPP and benzamidine than 
bovine /I-trypsin and human urokinase, is in agreement 
with the greater ability of the former to catalyse the 
hydrolysis of substrates containing arginine rather 
than lysine residues [ 11 ,121. 
The increase in the value of the dissociation con- 
stants. for the binding of benzamidine to bovine 
thrombin, human urinary kallikrein, bovine fl-trypsin 
and human urokinase, over pH 3-6, reflects according 
to linkage relations [ 141, an acid-shift in the pK of a 
group on binding the cation. Also TAPP binding to 
human urinary kallikrein, human urokinase and bovine 
/3-trypsin is similarly affected by pH. 
The pH dependence of the equilibrium constant 
for benzamidine binding to bovine /I-trypsin agrees 
with the results of proton release experiments [ 151. 
The simple model, involving a pK-shift of a single 
ionizable group on ligand binding leads to the follow- 
ing expression: 
logK=C+log(KUNL + @I) 
(KLIG + [H'l) (1) 
where C is a constant that corresponds to the acid 
asymptote of log K, and Ku,, and KLIG are the 
values of the proton dissociation constant for the 
ligand-free and ligand-bound enzymes, respectively 
(fig.l,2). 
In the TAPP binding to bovine thrombin the situa- 
tion is different. The curve for the pH dependence is 
so steep in relation to its amplitude that it cannot be 
fitted with eq. (1) by any choice of constants. In this 
case the involvement of at least two TAPP-linked pro- 
ton binding groups must be postulated. If the groups 
are inherently the same, the pH dependence may be 
expressed by the relation [ 141: 
logK=c+log(KuNL + [H’1)2 
(KLIG + W+D2 
(2) 
The good agreement between the calculated curve 
and the observations (fig.2) supports the idea that 
TAPP binding to bovine thrombin involves 2 equi- 
valent proton-binding groups. 
The pK-values of the groups involved in TAPP and 
benzamidine binding (table 1) are closely similar for 
the various enzymes and agree very well with the pK- 
Table 1 
pK-values of l&and-free (pKUNL) and ligand-bound (pKL1~) 
enzymes at 21’C 
TAPP Benzamidine 
Human pK”NL = 4.4 pKUNL = 4.4 
urokinase PKLIG = 3.9 PKLIG = 3.9 
Bovine pKUNL = 4.6 PKLJNL = 4.5 
P-trypsin pKLIG = 3.8 pKLIG = 3.7 
Human urinary pK,,NL = 4.6 pKUNL = 4.5 
kallikrein pKLIG =4.0 pKLIG = 3.9. 
Bovine PKUNL = 4.5 PKUNL = 4.6 
thrombin PKLIG = 3.7 PKLIG = 3.7 
pK-Values were determined by curve fitting from eq. (1) and 
(2); data in fig.1 and 2 
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values of the group involved, between pH 3-6, in the 
binding of cationic substrates [ 11,121. 
Inspection of the amino acid sequences [10,16-l 93 
and of the three-dimensional structures [ 10,20,21] of 
the various enzymes tudied here suggest that the 
ionizable group regulating TAPP binding to bovine 
/_I-trypsin, human urinary kallikrein and human uro- 
kinase can be identified with Asp-l 89. Moreover, also 
one of the 2 ionizations affecting TAPP binding to 
bovine thrombin can be assigned to Asp-l 89. This 
residue is known to interact with positively charged 
benzamidine in the specificity pocket of bovine 
@trypsin [21]; it is common to the primary structures 
of the 4 above-mentioned nzymes, and it has no 
counterpart in bovine cu-chymotrypsin a d in porcine 
pancreatic elastase, acting on neutral substrates. This 
fact is in agreement with the pH independence of the 
equilibrium constant for TAPP and benzamidine bind- 
ing to bovine cu-chymotrypsin. I  addition, the pres- 
ence, at the recognition site, of 2 residues howing an 
high steric hindrance, notably Val-216 and Thr-226, 
explains the absence of any inhibitory effect of TAPP 
and benzamidine on porcine pancreatic elastase catal- 
ysis. 
A tentative assignment can be given also for the 
second ionizing group found to affect TAPP binding 
to bovine thrombin. On the basis of simple stereo- 
chemical considerations, drawn on the analogous 
three-dimensional structures of bovine P-trypsin and 
of sequence comparisons, only Glu-149 and Asp-l 92 
residues of bovine thrombin seem to meet he require- 
ments for productive binding of a second TAPP ben- 
zamidine substituent. These 2 residues are unique to 
bovine thrombin, while no other negatively charged 
side chains appear to be accessible to TAPP once one 
of its benzamidine moiety is bound into the enzyme 
specificity pocket. 
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